Company intelligence / Profile preview

QED Communications

Oldwick, NJ, USA

Ownership: Private
Development stage: Other

Overview

QED Communications is a specialized medical communications agency that provides strategic and scientific support to the pharmaceutical, biotechnology, and medical device industries. The company focuses on medical affairs, publication planning, and the development of scientific content to support product launches and lifecycle management. Now a part of the Envision Pharma Group, QED Communications combines deep therapeutic expertise with innovative technology to deliver evidence-based communication strategies. Their services include medical writing, congress management, and advisory board facilitation, helping clients translate complex data into meaningful clinical narratives.

Industry: Consulting

Beyond the preview

Go deeper on QED Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QED Communications.

Explore the full profile